AWMG
ABBV icon

Alliance Wealth Management Group’s AbbVie ABBV Stock Holding History

Alliance Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,011
Closed -$234K – 95
2025
Q3 		$234K Buy
+1,011
New +$206K 0.05% 88
2017
Q4 		– Sell
-2,310
Closed -$204K – 73
2017
Q3 		$204K Buy
+2,310
New +$176K 0.05% 82

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Alliance Wealth Management Group's ABBV Position: Q4 2025 in Review

Alliance Wealth Management Group sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,011 shares — an estimated $234K sold.

Alliance Wealth Management Group first reported a position in ABBV in Q3 2017 and held it in 2 quarters. The position peaked at $234K in Q3 2025. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Alliance Wealth Management Group reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Alliance Wealth Management Group sold 1,011 AbbVie shares in Q4 2025, an estimated $234K.
  • Alliance Wealth Management Group first reported a position in AbbVie in Q3 2017 and held it in 2 quarters.
  • Alliance Wealth Management Group's AbbVie position peaked at $234K in Q3 2025.
  • 4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Alliance Wealth Management Group's 13F filing for Q4 2025, filed 21 Jan 2026.